These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8872177)

  • 1. The TAP complex influences allorecognition of class II MHC molecules.
    Carmichael P; Kerr LA; Kelly A; Lombardi G; Zeigler BU; Ziegler A; Trowsdale J; Lechler R
    Hum Immunol; 1996 Sep; 50(1):70-7. PubMed ID: 8872177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
    Lewis JW; Neisig A; Neefjes J; Elliott T
    Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.
    Teisserenc H; Schmitt W; Blake N; Dunbar R; Gadola S; Gross WL; Exley A; Cerundolo V
    Immunol Lett; 1997 Jun; 57(1-3):183-7. PubMed ID: 9232449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide selection by MHC-encoded TAP transporters.
    Momburg F; Neefjes JJ; Hämmerling GJ
    Curr Opin Immunol; 1994 Feb; 6(1):32-7. PubMed ID: 8172678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.
    Knittler MR; Alberts P; Deverson EV; Howard JC
    Curr Biol; 1999 Sep; 9(18):999-1008. PubMed ID: 10508608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
    Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
    J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
    Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
    Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
    Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
    Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of peptide binding by MHC class I molecules on their interaction with TAP.
    Grandea AG; Androlewicz MJ; Athwal RS; Geraghty DE; Spies T
    Science; 1995 Oct; 270(5233):105-8. PubMed ID: 7569935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
    Boyle LH; Goodall JC; Gaston JS
    Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism.
    Quadri SA; Singal DP
    Immunol Lett; 1998 Mar; 61(1):25-31. PubMed ID: 9562372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
    Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
    Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of the transport complex TAP in cellular immune recognition.
    Abele R; Tampé R
    Biochim Biophys Acta; 1999 Dec; 1461(2):405-19. PubMed ID: 10581370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of extrathymic CD8 alpha beta T cells in the liver and intestine in TAP-1 deficient mice.
    Tsukada C; Miyaji C; Kawamura H; Miyakawa R; Yokoyama H; Ishimoto Y; Miyazawa S; Watanabe H; Abo T
    Immunology; 2003 Jul; 109(3):343-50. PubMed ID: 12807479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
    Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
    Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.